{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T20:13:13Z","timestamp":1793995993294,"version":"4.8.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,27]],"date-time":"2020-11-27T00:00:00Z","timestamp":1606435200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,11,27]],"date-time":"2020-11-27T00:00:00Z","timestamp":1606435200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Despite coverage and benefits associated with the prevention of mothers to child transmission (PMTCT) services, mothers\u2019 adherence to option B plus is still a challenge. Though few primary studies are available on the magnitude of adherence to option B plus and factors associated in Eastern African countries, they do not provide strong evidence in helping policymakers to address suboptimal adherence to option B plus. Therefore, this systematic review and meta-analysis was intended to estimate the pooled magnitude of adherence to option B plus program and associated factors among women in Eastern African countries.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>PubMed, Medline, HINARI, Cochrane library, the Web of Science, and Google Scholar were searched for studies reported on the magnitude of adherence to option B plus among women in Eastern African countries. The search terms used were \u201coption B plus\u201d, \u201cmagnitude\u201d, \u201cprevalence\u201d, \u201cPMTCT\u201d, \u201cART adherence\u201d, \u201cassociated factors\u201d, \u201call lists of Eastern African countries\u201d and their combination by Boolean operators. The effect sizes of the meta-analysis were the magnitude of adherence to option B plus and the odds ratio of the associated factors. STATA\/SE V14 was used for statistical analysis, and publication bias was assessed using funnel plots and Egger\u2019s test.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Fourteen studies having total participants of 4883 were included in the systematic review and meta-analysis. Using the random effect model, the pooled prevalence of adherence to option B plus was 71.88% (95% CI: 58.54\u201385.23%). The factors associated with good adherence to option B plus PMTCT program were partner support (Adjusted odds ratio (AOR)\u2009=\u20094.13; 95% CI: 2.78\u20136.15), received counseling services (AOR\u2009=\u20094.12, 95% CI: 2.81\u20136.02), disclosure of HIV status to partner (AOR\u2009=\u20094.38; 95% CI: 1.79\u201310.70), and clinical stage of HIV\/AIDS I\/II (AOR\u2009=\u20092.62; 95% CI: 1.53\u20134.46).<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>The level of adherence to option B plus program in Eastern African countries was generally sub-optimal. Thus, a coordinated effort is needed to raise the number of mothers to be tested, and early treatment initiation for HIV positive mothers before the disease advances. Furthermore, counseling services for couples on the importance of early treatment initiation and adherence to medications must be given due attention.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12889-020-09903-y","type":"journal-article","created":{"date-parts":[[2020,11,27]],"date-time":"2020-11-27T10:02:45Z","timestamp":1606471365000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["The magnitude of adherence to option B plus program and associated factors among women in eastern African countries: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4721-3647","authenticated-orcid":false,"given":"Reta","family":"Tsegaye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werku","family":"Etafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bizuneh","family":"Wakuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Getu","family":"Mosisa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diriba","family":"Mulisa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadesse","family":"Tolossa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,27]]},"reference":[{"issue":"1","key":"9903_CR1","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1186\/s12879-018-3217-3","volume":"18","author":"GA Beyene","year":"2018","unstructured":"Beyene GA, Dadi LS, Mogas SB. Determinants of HIV infection among children born to mothers on prevention of mother to child transmission program of HIV in Addis Ababa, Ethiopia: a case control study. BMC Infect Dis. 2018;18(1):327.","journal-title":"BMC Infect Dis."},{"key":"9903_CR2","unstructured":"Joint United Nations Programme on HIV\/AIDS (UNAIDS). UNAIDS 2016\u20132021 Strategy: On the Fast-Track to end AIDS; 2016."},{"key":"9903_CR3","volume-title":"A progress report on the Global Plan towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive","author":"UNAIDS","year":"2012","unstructured":"UNAIDS. A progress report on the Global Plan towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive 2012."},{"key":"9903_CR4","unstructured":"HIV and AIDS in East and Southern Africa regional overview [Internet]. Available from: https:\/\/www.avert.org\/professionals\/hiv-around-world\/sub-saharan-africa\/overview."},{"key":"9903_CR5","volume-title":"Use Of Antiretroviral Drugs For Treating Pregnant Women And Preventing HIV Infection In Infants","author":"WHO. Programmatic Update","year":"2012","unstructured":"WHO. Programmatic Update. Use Of Antiretroviral Drugs For Treating Pregnant Women And Preventing HIV Infection In Infants 2012."},{"key":"9903_CR6","volume-title":"Options B and B+: Key considerations for countries to implement an equity -Focused approach","author":"UNICEF","year":"2012","unstructured":"UNICEF. Options B and B+: Key considerations for countries to implement an equity -Focused approach 2012."},{"key":"9903_CR7","doi-asserted-by":"publisher","first-page":"100459","DOI":"10.1016\/j.srhc.2019.100459","volume":"22","author":"M Tarekegn","year":"2019","unstructured":"Tarekegn M, Baru A, Seme A. Levels of option B+ ART drugs adherence and associated factors among pregnant women following ART services at public health facilities of East Shawa Zone, Oromia, Ethiopia. Sex Reprod Healthcare. 2019;22:100459.","journal-title":"Ethiopia. Sex Reprod Healthcare."},{"key":"9903_CR8","doi-asserted-by":"publisher","first-page":"162","DOI":"10.2471\/BLT.13.122523","volume":"92","author":"L O\u2019Brien","year":"2014","unstructured":"O\u2019Brien L, Shaffer N, Sangrujee N, Abimbola TO. The incremental cost of switching from option B to option B+ for the prevention of mother-to-child transmission of HIV. Bull World Health Organ. 2014;92:162\u201370.","journal-title":"Bull World Health Organ"},{"issue":"8","key":"9903_CR9","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1056\/NEJMra1505256","volume":"374","author":"K Luzuriaga","year":"2016","unstructured":"Luzuriaga K, Mofenson LM. Challenges in the elimination of pediatric HIV-1 infection. N Engl J Med. 2016;374(8):761-70.","journal-title":"N Engl J Med."},{"key":"9903_CR10","volume-title":"ELIMINATION OF MOTHER-TO-CHILD TRANSMISSION OF HIV AND SYPHILIS","author":"WHO","year":"2017","unstructured":"WHO. ELIMINATION OF MOTHER-TO-CHILD TRANSMISSION OF HIV AND SYPHILIS 2017."},{"issue":"9863","key":"9903_CR11","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/S0140-6736(12)61807-8","volume":"381","author":"A Coutsoudis","year":"2013","unstructured":"Coutsoudis A, Goga A, Desmond C, VB PB, Coovadia H. Is option B+ the best choice? Lancet. 2013;381(9863):269\u201371.","journal-title":"Lancet"},{"key":"9903_CR12","doi-asserted-by":"publisher","first-page":"e2016043","DOI":"10.4178\/epih.e2016043","volume":"38","author":"D Tsegaye","year":"2016","unstructured":"Tsegaye D, Deribe L, Wodajo S. Levels of adherence and factors associated with adherence to option B+ prevention of mother-to-child transmission among pregnant and lactating mothers in selected government health facilities of south Wollo zone, Amhara region, Northeast Ethiopia, 2016. Epidemiol Health. 2016;38:e2016043.","journal-title":"Epidemiol Health"},{"key":"9903_CR13","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ijid.2014.12.026","volume":"33","author":"H Ebuy","year":"2015","unstructured":"Ebuy H, Yebyo H, Alemayehu M. Level of adherence and predictors of adherence to the option B+ PMTCT programme in Tigray, northern Ethiopia. Int J Infect Dis. 2015;33:123\u20139.","journal-title":"Int J Infect Dis"},{"issue":"1","key":"9903_CR14","doi-asserted-by":"publisher","first-page":"e0188488","DOI":"10.1371\/journal.pone.0188488","volume":"13","author":"H Tweya","year":"2018","unstructured":"Tweya H, Oboho IK, Gugsa ST, Phiri S, Rambiki E, Banda R, Mwafilaso J, Munthali C, Gupta S, Bateganya M, Maida A. Loss to follow-up before and after initiation of antiretroviral therapy in HIV facilities in Lilongwe, Malawi. PloS One. 2018;13(1):e0188488.","journal-title":"PloS One."},{"issue":"2","key":"9903_CR15","doi-asserted-by":"publisher","first-page":"e0212587","DOI":"10.1371\/journal.pone.0212587","volume":"14","author":"KM Zacharius","year":"2019","unstructured":"Zacharius KM, Basinda N, Marwa K, Mtui EH, Kalolo A, Kapesa A. Low adherence to Option B+ antiretroviral therapy among pregnant women and lactating mothers in eastern Tanzania. PloS one. 2019;14(2):e0212587.","journal-title":"PloS one."},{"issue":"1","key":"9903_CR16","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s12884-019-2228-4","volume":"19","author":"DJ Tesfaye","year":"2019","unstructured":"Tesfaye DJ, Hibistu DT, Abebo TA, Asfaw FT, Lukas K, Laelago T, et al. Option B plus antiretroviral therapy adherence and associated factors among HIV positive pregnant women in southern Ethiopia. BMC Pregnancy Childbirth. 2019;19(1):82.","journal-title":"BMC Pregnancy Childbirth"},{"key":"9903_CR17","doi-asserted-by":"crossref","unstructured":"Mukui IN, Ng\u2019ang\u2019a L, Williamson J, Wamicwe JN, Vakil S, Katana A, Kim AA. Rates and predictors of non-adherence to antiretroviral therapy among HIV-positive individuals in Kenya: results from the second Kenya AIDS indicator survey, 2012. PloS one. 2016;11(12):e0167465.","DOI":"10.1371\/journal.pone.0167465"},{"key":"9903_CR18","doi-asserted-by":"crossref","unstructured":"Tweya H, Gugsa S, Hosseinipour M, Speight C, Ng'ambi W, Bokosi M, Chikonda J, Chauma A, Khomani P, Phoso M, Mtande T. Understanding factors, outcomes and reasons for loss to follow\u2010up among women in O ption B+ PMTCT programme in L ilongwe, Malawi. Trop Med Int Health. 2014;19(11):1360-6.","DOI":"10.1111\/tmi.12369"},{"issue":"4","key":"9903_CR19","doi-asserted-by":"publisher","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","volume":"151","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264\u20139.","journal-title":"Ann Intern Med"},{"key":"9903_CR20","volume-title":"Development of a multi-method tool to measure ART adherence in resource-constrained settings: the South Africa experience","author":"G Steel","year":"2007","unstructured":"Steel G, Nwokike J, Joshi MP. Development of a multi-method tool to measure ART adherence in resource-constrained settings: the South Africa experience; 2007 [cited 2016 Oct 25]. Available from: http:\/\/ apps.who.int\/medicinedocs\/documents\/s21890en\/s21890en.pdf."},{"key":"9903_CR21","unstructured":"JBI_Critical_AppraisalChecklist_for_Systematic_Reviews https:\/\/joannabriggs.org\/sites\/default\/files\/201905\/JBI_Critical_Appraisal-Checklist_for_Systematic_Reviews2017_0.pdf [Internet]. 2017."},{"issue":"4","key":"9903_CR22","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1007\/s12350-015-0249-6","volume":"23","author":"BJ George","year":"2016","unstructured":"George BJ, Aban IB. An application of meta-analysis based on DerSimonian and Laird method. J Nucl Cardiol. 2016;23(4):690\u20132.","journal-title":"J Nucl Cardiol"},{"key":"9903_CR23","doi-asserted-by":"publisher","first-page":"18","DOI":"10.4172\/1948-5964.1000175","volume":"10","author":"W Shibabaw","year":"2018","unstructured":"Shibabaw W, Melkam W, Shiabbaw A. Adherence to anti-retroviral therapy among HIV positive pregnant women in Ayder Refferal hospital, Northern Ethiopia. J Antivir Antiretrovir. 2018;10:18\u201322.","journal-title":"J Antivir Antiretrovir"},{"issue":"1","key":"9903_CR24","first-page":"2","volume":"2","author":"M Lencha","year":"2018","unstructured":"Lencha M. Adherence to option B+ and associated factors among pregnant women on PMTCT Services at Public Health Facilities of east Shawa zone, Oromia, Ethiopia. J Womens Health Reprod Med. 2018;2(1):2.","journal-title":"J Womens Health Reprod Med"},{"issue":"1","key":"9903_CR25","first-page":"39","volume":"2","author":"TM Lodebo","year":"2017","unstructured":"Lodebo TM, Suloro JA. Level of adherence and associated factors to option B+ PMTCT among HIV positive pregnant women in Hadiya zone, southern Ethiopia. Global J Health Sci. 2017;2(1):39\u201358.","journal-title":"Global J Health Sci"},{"issue":"3","key":"9903_CR26","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1089\/apc.2015.0318","volume":"30","author":"A Schnack","year":"2016","unstructured":"Schnack A, Rempis E, Decker S, Braun V, Rubaihayo J, Busingye P, et al. Prevention of mother-to-child transmission of HIV in option B+ era: uptake and adherence during pregnancy in Western Uganda. AIDS Patient Care STDs. 2016;30(3):110\u20138.","journal-title":"AIDS Patient Care STDs"},{"issue":"1","key":"9903_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12884-015-0697-7","volume":"15","author":"S Okawa","year":"2015","unstructured":"Okawa S, Chirwa M, Ishikawa N, Kapyata H, Msiska CY, Syakantu G, et al. Longitudinal adherence to antiretroviral drugs for preventing mother-to-child transmission of HIV in Zambia. BMC Pregnancy Childbirth. 2015;15(1):1\u201310.","journal-title":"BMC Pregnancy Childbirth"},{"issue":"9","key":"9903_CR28","first-page":"1227","volume":"63","author":"AD Haas","year":"2016","unstructured":"Haas AD, Msukwa MT, Egger M, Tenthani L, Tweya H, Jahn A, et al. Adherence to antiretroviral therapy during and after pregnancy: cohort study on women receiving care in Malawi's option B+ program. Clin Infect Dis. 2016;63(9):1227\u201335.","journal-title":"Clin Infect Dis"},{"key":"9903_CR29","volume-title":"Comparison of level and predictors of adherence to art option b+ between HIV infected pregnant and lactating women at Mnazi Mmoja hospital Dar es salam Tanzania: Muhimbili University of health and allied sciences","author":"EO Mwalumuli","year":"2017","unstructured":"Mwalumuli EO. Comparison of level and predictors of adherence to art option b+ between HIV infected pregnant and lactating women at Mnazi Mmoja hospital Dar es salam Tanzania: Muhimbili University of health and allied sciences; 2017."},{"key":"9903_CR30","doi-asserted-by":"publisher","first-page":"S198","DOI":"10.1097\/QAI.0000000000001347","volume":"75","author":"AS Erlwanger","year":"2017","unstructured":"Erlwanger AS, Joseph J, Gotora T, Muzunze B, Orne-Gliemann J, Mukungunugwa S, et al. Patterns of HIV care clinic attendance and adherence to antiretroviral therapy among pregnant and breastfeeding women living with HIV in the context of option B+ in Zimbabwe. J Acquir Immune Defic Syndr. 2017;75:S198\u2013206.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"10","key":"9903_CR31","doi-asserted-by":"publisher","first-page":"301","DOI":"10.18203\/issn.2454-2156.IntJSciRep20194252","volume":"5","author":"Y Demelash","year":"2019","unstructured":"Demelash Y, Abebe N, Sharew Y, Mehare T. Adherence of option B+ prevention of mother-to-child transmission program and its associated factors among pregnant and lactating mothers in public health facilities of east Gojjam zone, Amhara region, Ethiopia, 2017. Int J Sci Rep. 2019;5(10):301.","journal-title":"Int J Sci Rep"},{"issue":"1","key":"9903_CR32","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s12879-018-3087-8","volume":"18","author":"OV Adeniyi","year":"2018","unstructured":"Adeniyi OV, Ajayi AI, Ter Goon D, Owolabi EO, Eboh A, Lambert J. Factors affecting adherence to antiretroviral therapy among pregnant women in the Eastern Cape, South Africa. BMC Infect Dis. 2018;18(1):175.","journal-title":"BMC Infect Dis."},{"issue":"6","key":"9903_CR33","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1080\/09540121.2010.516341","volume":"23","author":"SM ZZ","year":"2011","unstructured":"ZZ SM, Mbuyazia A, Mkhwanazia N, M.L. Newella B. Challenges in PMTCT antiretroviral adherence in northern KwaZulu-Natal, South Africa. AIDS Care. 2011;23(6):741\u20137.","journal-title":"AIDS Care"},{"issue":"8","key":"9903_CR34","doi-asserted-by":"publisher","first-page":"e0201955","DOI":"10.1371\/journal.pone.0201955","volume":"13","author":"M Maskew","year":"2018","unstructured":"Maskew M, Jamieson L, Mohomi G, Long L, Mongwenyana C, Nyoni C, Mokaba D, Fox MP, Sanne I, Rosen S. Implementation of Option B and a fixed-dose combination antiretroviral regimen for prevention of mother-to-child transmission of HIV in South Africa: A model of uptake and adherence to care. PloS one. 2018;13(8):e0201955.","journal-title":"PloS one."},{"issue":"6","key":"9903_CR35","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1080\/09540121.2013.855300","volume":"26","author":"S Black","year":"2014","unstructured":"Black S, Zulliger R, Marcus R, Mark D, Myer L, Bekker L-G. Acceptability and challenges of rapid ART initiation among pregnant women in a pilot programme, Cape Town, South Africa. AIDS Care. 2014;26(6):736\u201341.","journal-title":"AIDS Care"},{"issue":"16","key":"9903_CR36","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1097\/QAD.0b013e328359590f","volume":"26","author":"JB Nachega","year":"2012","unstructured":"Nachega JB, Uthman OA, Anderson J, Peltzer K, Wampold S, Cotton MF, et al. Adherence to antiretroviral therapy during and after pregnancy in low-income, middle-income, and high-income countries: a systematic review and meta-analysis. AIDS. 2012;26(16):2039\u201352.","journal-title":"AIDS."},{"key":"9903_CR37","volume-title":"Department of Health and Human Services, Health Resources and Services Administration, Guide for HIV\/AIDS Clinical Care \u2013 2014 Edition","author":"U.S","year":"2014","unstructured":"U.S. Department of Health and Human Services, Health Resources and Services Administration, Guide for HIV\/AIDS Clinical Care \u2013 2014 Edition. Rockville, MD: U.S. Department of Health and Human Services; 2014."},{"issue":"1","key":"9903_CR38","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1186\/s12879-019-4341-4","volume":"19","author":"A Larsen","year":"2019","unstructured":"Larsen A, Magasana V, Dinh TH, Ngandu N, Lombard C, Cheyip M, Ayalew K, Chirinda W, Kindra G, Jackson D, Goga A. Longitudinal adherence to maternal antiretroviral therapy and infant Nevirapine prophylaxis from 6 weeks to 18 months postpartum amongst a cohort of mothers and infants in South Africa. BMC Infect Dis. 2019;19(1):789.","journal-title":"BMC Infect Dis."},{"key":"9903_CR39","volume-title":"Guidelines For Managing Advanced HIV Disease and rapid initiation of antiretroviral therapy","author":"WHO","year":"2017","unstructured":"WHO. Guidelines For Managing Advanced HIV Disease and rapid initiation of antiretroviral therapy. 2017."}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-020-09903-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12889-020-09903-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-020-09903-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,27]],"date-time":"2020-11-27T10:06:25Z","timestamp":1606471585000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-020-09903-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,27]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["9903"],"URL":"https:\/\/doi.org\/10.1186\/s12889-020-09903-y","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,27]]},"assertion":[{"value":"3 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1812"}}